Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2026-02-23 @ 11:35 AM
Study NCT ID:
NCT03034967
Status:
COMPLETED
Last Update Posted:
2020-10-28
First Post:
2017-01-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-25
Start Date Type:
ACTUAL
Primary Completion Date:
2018-10-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-10-05
Completion Date Type:
ACTUAL
First Submit Date:
2017-01-25
First Submit QC Date:
None
Study First Post Date:
2017-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-09-27
Results First Submit QC Date:
None
Results First Post Date:
2019-11-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-06
Last Update Post Date:
2020-10-28
Last Update Post Date Type:
ACTUAL